Evidence map›Paper›PMID 36438901›Full record

ArticleDisease markers2022

Development of Machine Learning Tools for Predicting Coronary Artery Disease in the Chinese Population.

Tiexu Zhang, Shengming Huang, Pengfei Xie, Xiaoming Li, Yingxia Pan, Yue Xu, Peng Han, Feifei Ding, Jiangman Zhao, Hui Tang

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tiexu ZhangDepartment of Cardiovascular Medicine, The First People's Hospital of Pingdingshan, Pingdingshan 467000, China.ORCID https://orcid.org/0000-0002-3358-8168
Shengming HuangDepartment of Internal Medicine, Luohe Central Hospital, Luohe, 462000 Henan, China.ORCID https://orcid.org/0000-0002-0884-1504
Pengfei XieDepartment of Cardiovascular Medicine, The First People's Hospital of Pingdingshan, Pingdingshan 467000, China.ORCID https://orcid.org/0000-0001-8266-8191
Xiaoming LiShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0003-0299-0987
Yingxia PanShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0003-0325-4367
Yue XuShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0002-5461-5495
Peng HanShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0001-9142-0032
Feifei DingShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0003-2313-1364
Jiangman ZhaoShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0001-6572-6177
Hui TangShanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai 201204, China.ORCID https://orcid.org/0000-0002-7429-1627
Pingdingshan University · CNLuohe Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Coronary artery disease (CAD) is one of the major cardiovascular diseases and the leading cause of death globally. Blood lipid profile is associated with CAD early risk. Therefore, we aim to establish machine learning models utilizing blood lipid profile to predict CAD risk. Methods: In this study, 193 non-CAD controls and 2001 newly-diagnosed CAD patients (1647 CAD patients who received lipid-lowering therapy and 354 who did not) were recruited. Clinical data and the result of routine blood lipids tests were collected. Moreover, low-density lipoprotein cholesterol (LDL-C) subfractions (LDLC-1 to LDLC-7) were classified and quantified using the Lipoprint system. Six predictive models (k-nearest neighbor classifier (KNN), logistic regression (LR), support vector machine (SVM), decision tree (DT), multilayer perceptron (MLP), and extreme gradient boosting (XGBoost)) were established and evaluated by the confusion matrix, area under the receiver operating characteristic (ROC) curve (AUC), recall (sensitivity), accuracy, precision, and F1 score. The selected features were analyzed and ranked. Results: While predicting the CAD development risk of the CAD patients without lipid-lowering therapy in the test set, all models obtained AUC values above 0.94, and the accuracy, precision, recall, and F1 score were above 0.84, 0.85, 0.92, and 0.88, respectively. While predicting the CAD development risk of all CAD patients in the test set, all models obtained AUC values above 0.91, and the accuracy, precision, recall, and F1 score were above 0.87, 0.94, 0.87, and 0.92, respectively. Importantly, small dense LDL-C (sdLDL-C) and LDLC-4 play pivotal roles in predicting CAD risk. Conclusions: In the present study, machine learning tools combining both clinical data and blood lipid profile showed excellent overall predictive power. It suggests that machine learning tools are suitable for predicting the risk of CAD development in the near future.

Indexed as

Coronary Artery DiseaseAsian PeopleChinaCholesterol, LDLHumansMachine LearningCholesterol, LDL

Identifiers

PMID36438901
PMCPMC9691305
OpenAlexW4309263530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.